288 related articles for article (PubMed ID: 5998755)
1. [Clinical study of the analgesic and anti-inflammatory activity of AF-864 (benzydamine hydrochloride) in otorhinolaryngology].
Di Fede S
Policlinico Prat; 1966 Nov; 73(46):1540-5. PubMed ID: 5998755
[No Abstract] [Full Text] [Related]
2. [Clinical experience with Riripen tablet (benzydamine hydrochloride) in otorhinolaryngology].
Hayakawa A; Watanabe M; Konago M; Yoneyama H
Jibiinkoka; 1968 Mar; 40(3):259-61. PubMed ID: 4877931
[No Abstract] [Full Text] [Related]
3. [Clinical experiences with benzydamine hydrochloride (Riripen) in otolaryngology].
Igarashi H
Jibiinkoka; 1968 May; 40(5):407-10. PubMed ID: 5750879
[No Abstract] [Full Text] [Related]
4. [Clinical use of IP-82 in otorhinolaryngology].
Sakamoto S; Kometani T; Ishimoda M; Takeuchi T; Saito H
Jibiinkoka; 1970 Jul; 42(7):559-62. PubMed ID: 5466256
[No Abstract] [Full Text] [Related]
5. [Results and considerations in the use of an anti-inflammatory and analgesic preparation in otorhinolaryngology].
Girardi G
Minerva Med; 1967 Apr; 58(32):1487-9. PubMed ID: 6029515
[No Abstract] [Full Text] [Related]
6. [Advantages of a painless and colorless topical agent in otorhinolaryngology].
Appaix A; Dinand F; Houel B
Mars Med; 1971; 108(1):79-81. PubMed ID: 4323276
[No Abstract] [Full Text] [Related]
7. [Value of niflumic acid in otorhinolaryngology].
Portmann M; Pardes P
Rev Laryngol Otol Rhinol (Bord); 1968; 89(7):494-8. PubMed ID: 5715347
[No Abstract] [Full Text] [Related]
8. [Experience with Chymar in otorhinolaryngology].
Nagai T; Ushijima S; Furuichi N; Iwatake Y; Shiga K
Jibiinkoka; 1967 Feb; 39(2):191-4. PubMed ID: 6070563
[No Abstract] [Full Text] [Related]
9. [Evaluation of the therapeutic activity and tolerability of difenpiramide in otorhinolaryngology].
Lunghi F; Blasi M; Frasson P; Lunghi M; Giusti P
Clin Ter; 1982 Dec; 103(6):635-45. PubMed ID: 7160146
[No Abstract] [Full Text] [Related]
10. [Remarks and results obtained with an antiphlogistic and analgesic preparation in otorhinolaryngology].
Girardi G
Minerva Otorinolaringol; 1967; 17(5):115-8. PubMed ID: 5611123
[No Abstract] [Full Text] [Related]
11. [Use of a new antalgic anti-inflammatory agent in otorhinolaryngology].
Portmann M; Pardes P
Rev Laryngol Otol Rhinol (Bord); 1971; 92(3):235-8. PubMed ID: 5565287
[No Abstract] [Full Text] [Related]
12. [Therapeutic experience in the use of Mebron tablet (DA-398) in otorhinolaryngologic field].
Kono K; Sekine K
Jibiinkoka; 1970 Sep; 42(9):711-3. PubMed ID: 5466086
[No Abstract] [Full Text] [Related]
13. [Calcium bucloxate: its use in ORL inflammatory pathology].
Gaillard J; Dumolard P
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Feb; 24(2):153-5. PubMed ID: 123947
[No Abstract] [Full Text] [Related]
14. [Clinical trial of an antibiotic and decongestant combination: proxibron].
Haguenauer JP; Bouchayer M; Jacquemard C
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Apr; 18(4):247-9. PubMed ID: 4249627
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation of a new anti-inflammatory agent in the field of otorhinolaryngology].
Roux O
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Sep; 24(7):545-7. PubMed ID: 129512
[No Abstract] [Full Text] [Related]
16. [Note on a new anti-inflammatory agent in otorhinolaryngology].
Lacher G
Rev Laryngol Otol Rhinol (Bord); 1968; 89(7):499-501. PubMed ID: 5715348
[No Abstract] [Full Text] [Related]
17. [Further contributions on the therapeutic action of Febutol in ORL].
Perrella F; Alinei D
Minerva Otorinolaringol; 1968; 18(2):94-8. PubMed ID: 5741565
[No Abstract] [Full Text] [Related]
18. [The results of clinical observations and experimental research of some preparations produced by the pharmaceutic industry plant "Polfa" (author's transl)].
Semczuk B
Ann Univ Mariae Curie Sklodowska Med; 1979; 34():291-6. PubMed ID: 400433
[No Abstract] [Full Text] [Related]
19. [Study of Elarzone-Dausse, a new E.N.T. anti-inflammatory agent].
Ammar-Khodja A
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):665-6 passim. PubMed ID: 4280432
[No Abstract] [Full Text] [Related]
20. [Consensus conference on the rationale for use of anti-inflammatory agents in otorhinolaryngology].
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):5-40. PubMed ID: 15462021
[No Abstract] [Full Text] [Related]
[Next] [New Search]
